M&A Deal Summary

Par Pharmaceutical Companies Acquires JHP Pharmaceuticals

On January 21, 2014, Par Pharmaceutical Companies acquired healthcare services company JHP Pharmaceuticals from Warburg Pincus for 490M USD

Acquisition Highlights
  • This is Par Pharmaceutical Companies’ 1st transaction in the Healthcare Services sector.
  • This is Par Pharmaceutical Companies’ largest (disclosed) transaction.
  • This is Par Pharmaceutical Companies’ 2nd transaction in the United States.
  • This is Par Pharmaceutical Companies’ 1st transaction in New Jersey.

M&A Deal Summary
Date 2014-01-21
Target JHP Pharmaceuticals
Sector Healthcare Services
Buyer(s) Par Pharmaceutical Companies
Sellers(s) Warburg Pincus
Deal Type Add-on Acquisition
Deal Value 490M USD
Advisor(s) J.P. Morgan Securities (Financial)
Willkie Farr & Gallagher (Legal)

Target

JHP Pharmaceuticals

Parsippany, New Jersey, United States
JHP, headquartered in New Jersey, is a fully integrated specialty pharmaceutical company that acquires, develops, manufactures and sells sterile injectable products. JHP's sterile manufacturing facility, located in Rochester, Michigan, sits on over 80 acres of land and includes a 171,000 sq. ft. production building and warehouse. JHP employs more than 370 staff in the USA in its manufacturing, product development, sales & marketing and corporate areas.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Par Pharmaceutical Companies

Woodcliff Lake, New Jersey, United States
Category Company
Founded 1978
Sector Life Science
Employees978
Revenue 1.3B USD (2014)
DESCRIPTION

Par Pharma specializes in developing, licensing, manufacturing, marketing and distributing generic drugs.

DEAL STATS #
Overall 2 of 2
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 2 of 2
State (New Jersey) 1 of 1
Country (United States) 2 of 2
Year (2014) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-10-22 Par Pharmaceutical - Research and Development Capabilities

United States

Par Pharmaceutical Co., Inc. - Research and Development Capabilities provides pharmaceutical services.

Sell -

Seller(S) 1

SELLER

Warburg Pincus

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1966
PE ASSETS 83.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.

DEAL STATS #
Overall 100 of 251
Sector (Healthcare Services) 6 of 14
Type (Add-on Acquisition) 38 of 90
State (New Jersey) 4 of 4
Country (United States) 65 of 137
Year (2014) 1 of 9
Size (of disclosed) 38 of 63
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-01-09 ComplexCare Solutions

New York, New York, United States

ComplexCare Solutions (CCS) is a New York-based health services company with service centers in New York, Tennessee, and Puerto Rico. ComplexCare specializes in face-to-face services for Medicare Advantage, Managed Long Term Care (MLTC), Medicaid, SNP, and commercial plan members. CCS is focused on integrating the continuum of care for complex, frail, elderly, special needs, and dually-eligible individuals.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-01-23 Santander Consumer USA

Dallas, Texas, United States

Santander Consumer USA is a provider of financial services for vehicle and consumer lending products. Santander Consumer USA was founded in 1995 and is based in Dallas, Texas.

Sell -
Mergr

Product

Company

Legal